Publication Cover
Journal of Environmental Science and Health, Part C
Environmental Carcinogenesis and Ecotoxicology Reviews
Volume 35, 2017 - Issue 2
258
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids

, &

References

  • Cook JW, Duffy E, Schoental R. Primary liver tumours in rats following feeding with alkaloids of Senecio jacobaea. Br J Cancer. 1950;4:405–410.
  • Edgar JA, Molyneux RJ, Colegate SM. Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease. Chem Res Toxicol. 2015;28:4–20.
  • Fu PP. Pyrrolizidine Alkaloids: Metabolic activation pathways leading to liver tumor initiation. Chem Res Toxicol. 2017;30:81–93.
  • Fu PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 2004;36:1–55.
  • International Programme on Chemical Safety. Pyrrolizidine alkaloids health and safety guide. Health and Safety Criteria Guide 26; International Programme on Chemical Safety. Geneva, Switzerland: WHO; 1989:19.
  • Mattocks AR. Chemistry and Toxicology of Pyrrolizidine Alkaloids. London; New York: Academic Press; 1986.
  • Wiedenfeld H. Toxicity of pyrrolizidine alkaloids—a serious health problem. MÜSBED. 2011;1:79–87.
  • Schoental R, Head MA, Peacock PR. Senecio alkaloids: Primary liver tumours in rats as a result of treatment with (1) a mixture of alkaloids from S. jacobaea lin.; (2) retrorsine; (3) isatidine. Br J Cancer. 1954;8:458–465.
  • Ruan J, Yang M, Fu P, Ye Y, Lin G. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis. Chem Res Toxicol. 2014;27:1030–1039.
  • Chou MW, Wang YP, Yan J, Yang Y-C, Beger RD, et al. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol Lett. 2003;145:239–247.
  • Coulombe RA, Jr., Drew GL, Stermitz FR. Pyrrolizidine alkaloids crosslink DNA with actin. Toxicol Appl Pharmacol. 1999;154:198–202.
  • Fu PP, Chou MW, Churchwell M, Wang Y, Zhao Y, et al. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo. Chem Res Toxicol. 2010;23:637–652.
  • Fu PP, Chou MW, Xia Q, Yang Y-C, Yan J, et al. Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides—mechanisms leading to DNA adduct formation and tumorigenicity. J Environ Sci Health, Part C. 2001;19:353–385.
  • Hincks JR, Kim H-Y, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA, Jr. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity relationships. Toxicol Appl Pharmacol. 1991;111:90–98.
  • Kim H-Y, Stermitz FR, Coulombe RAJ. Pyrrolizidine alkaloid-induced DNA-protein cross-links. Carcinogenesis. 1995;16:2691–2697.
  • Kim H-Y, Stermitz FR, Li JK-K, Coulombe RAJ. Comparative DNA cross-linking by activated pyrrolizidine alkaloids. Food Chem Toxicol. 1999;37:619–625.
  • Wang YP, Fu PP, Chou MW. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Int J Environ Res Public Health. 2005;2:74–79.
  • Wang YP, Yan J, Beger RD, Fu PP, Chou MW. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Cancer Lett. 2005;226:27–35.
  • Wang YP, Yan J, Fu PP, Chou MW. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Toxicol Lett. 2005;155:411–420.
  • Xia Q, Chou MW, Edgar JA, Doerge DR, Fu PP. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine. Cancer Lett. 2006;231:138–145.
  • Xia Q, Chou MW, Kadlubar FF, Chan P-C, Fu PP. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem Res Toxicol. 2003;16:66–73.
  • Xia Q, Chou MW, Lin G, Fu PP. Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii hook. Chem Res Toxicol. 2004;17:702–708.
  • Xia Q, Ma L, He X, Cai L, Fu PP. 7-Glutathione pyrrole adduct: a potential DNA reactive metabolite of pyrrolizidine alkaloids. Chem Res Toxicol. 2015;28:615–620.
  • Xia Q, Yan J, Chou MW, Fu PP. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Toxicol Lett. 2008;178:77–82.
  • Yan CC, Cooper RA, Huxtable RJ. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver. Toxicol Appl Pharmacol. 1995;133:277–284.
  • Yang Y-C, Yan J, Doerge DR, Chan P-C, Fu PP, Chou MW. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo. Chem Res Toxicol. 2001;14:101–109.
  • Zhao Y, Xia Q, Gamboa da Costa G, Yu H, Cai L, Fu PP. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation. Chem Res Toxicol. 2012;25:1985–1996.
  • Xia Q, Zhao Y, Von Tungeln LS, Doerge DR, Lin G, et al. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Chem Res Toxicol. 2013;26:1384–1396.
  • Yang Y, Yan J, Churchwell M, Beger R, Chan P, et al. Development of a (32)P-postlabeling/HPLC method for detection of dehydroretronecine-derived DNA adducts in vivo and in vitro. Chem Res Toxicol. 2001;14:91–100.
  • Zhu L, Xue J, Xia Q, Fu PP, Lin G. The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice. Arch Toxicol. 2017;91:949–965.
  • Chou MW, Fu PP. Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids. Toxicol Ind Health. 2006;22:321–327.
  • Yan J, Xia Q, Chou MW, Fu PP. Metabolic activation of retronecine and retronecine N-oxide—formation of DHP-derived DNA adducts. Toxicol Ind Health. 2008;24:181–188.
  • Cooper RA, Huxtable RJ. A simple procedure for determining the aqueous half-lives of pyrrolic metabolites of pyrrolizidine alkaloids. Toxicon. 1996;34:604–607.
  • Chen M, Li L, Zhong D, Shen S, Zheng J, Chen X. 9-Glutathionyl-6, 7-dihydro-1-hydroxymethyl-5 H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats. Chem Res Toxicol. 2016;29:180–189.
  • Lame MW, Morin D, Jones AD, Segall HJ, Wilson DW. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol Lett. 1990;51:321–329.
  • Lin G, Cui YY, Hawes EM. Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine. Firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos. 1998;26:181–184.
  • Reed RL, Miranda CL, Kedzierski B, Henderson MC, Buhler DR. Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine. Xenobiotica. 1992;22:1321–1327.
  • He X, Xia Q, Ma L, Fu PP. 7-Cysteinyl-pyrrole conjugate-a new potential DNA reactive metabolite of pyrrolizidine alkaloids. J Environ Sci Health, Part C. 2016;34:57–76.
  • Ma L, Zhao H, Xia Q, Cai L, Fu PP. Synthesis and phototoxicity of isomeric 7, 9-diglutathione pyrrole adducts: Formation of reactive oxygen species and induction of lipid peroxidation. J Food Drug Anal. 2015;23:577–586.
  • Churchwell MI, Beland FA, Doerge DR. Quantification of O6-methyl and O6-ethyl deoxyguanosine adducts in C57BL/6N/Tk+/− mice using LC/MS/MS. J Chromat B. 2006;844:60–66.
  • Fu PP, Xia Q, He X, Barel S, Edery N, et al. Detection of pyrrolizidine alkaloid DNA adducts in livers of cattle poisoned with heliotropium europaeum. Chem Res Toxicol. 2017; DOI:10.102/acs.chemrestox.6b00456
  • Buhler DR, Miranda CL, Kedzierski B, Reed RL. Mechanisms for pyrrolizidine alkaloid activation and detoxification. Adv Exp Med Biol. 1991;283:597–603.
  • Ji L, Liu T, Chen Y, Wang Z. Protective mechanisms of N-acetyl-cysteine against pyrrolizidine alkaloid clivorine-induced hepatotoxicity. J Cell Biochem. 2009;108:424–432.
  • Neuman MG, Jia AY, Steenkamp V. Senecio latifolius induces in vitro hepatocytotoxicity in a human cell line. Can J Physiol Pharmacol. 2007;85:1063–1075.
  • Yan CC, Huxtable RJ. Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat. Biochem Pharmacol. 1996;51:375–379.
  • Yan CC, Huxtable RJ. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat. Toxicon. 1995;33:627–634.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.